Literature DB >> 4337882

Tumor-inhibitory effect of a streptococcal preparation (NSC-B116209).

S Tsukagoshi, Y Sakurai, H Sato, S Akiba T SUZUKI.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4337882

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  22 in total

1.  Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.

Authors:  M Saito; O Ichimura; M Kataoka; Y Moriya; K Ueno; Y Sugawara; M Nanjo; N Ishida
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Autoimmune kidney disease in MRL/Mp-lpr/lpr mice inhibited by OK-432, a streptococcal preparation.

Authors:  M Mihara; Y Ohsugi
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

3.  An adhesive glycoprotein from rat ascites hepatoma cells potentiates natural cytotoxic activity by rat spleen cells.

Authors:  J Y Chen; R Kurano; M Hirashima; H Hayashi
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

4.  Inhibition of in vitro LAK generation by OK-432.

Authors:  M Yagita; E A Grimm
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Re-evaluation of immunological parameters in immunotherapy for advanced carcinoma of the digestive tract.

Authors:  H Hanaue; S Yoshizaki; T Kurosawa
Journal:  Gastroenterol Jpn       Date:  1983-08

6.  Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors.

Authors:  H Wakasugi; K Oshimi; M Miyata; Y Morioka
Journal:  J Clin Immunol       Date:  1981-07       Impact factor: 8.317

7.  Pharmacological studies on a plant lectin, Aloctin A. I. Growth inhibition of mouse methylcholanthrene-induced fibrosarcoma (Meth A) in ascites form by Aloctin A.

Authors:  K Imanishi; T Ishiguro; H Saito; I Suzuki
Journal:  Experientia       Date:  1981-11-15

8.  The clinical efficacy of intratumoral OK-432 administration in advanced cancer patients.

Authors:  T Toge; H Kuninobu; Y Yamaguchi; N Baba; Y Kegoya; T Hattori
Journal:  Jpn J Surg       Date:  1988-11

9.  Studies on the immunopotentiating effects of a streptococcal preparation, OK-432. I. Enhancement of T cell-mediated immune responses of mice.

Authors:  S Kai; J Tanaka; K Nomoto; M Torisu
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

10.  Postoperative chemotherapy including intraperitoneal and intradermal administration of the streptococcal preparation OK-432 for patients with gastric cancer and peritoneal dissemination: a prospective randomized study.

Authors:  K Sugimachi; Y Maehara; K Akazawa; Y Kondo; Y Kunii; M Kitamura; H Yamaoka; Y Takahashi; T Kito; M Katou
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.